Enbrel to be launched in Korea

Published: 2004-05-04 07:00:00
Updated: 2004-05-04 07:00:00
Wyeth Korea said it plans to launch Enbrel (etanercept) for the treatment of rheumatoid arthritis (RA) from May 29, as the third country in Asia following Australia and Taiwan.

Enbrel is the only biologic therapy approved to reduce signs and symptoms, improve physical function, and inhibit the...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.